Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-20-017592)

Filing Details

Accession Number:: 0001567619-20-017592
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-10-05 17:33:16
Reporting Period:: 2020-10-01

Accepted Time:: 2020-10-05 17:33:16
Original Submission Date:: 2020-10-05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533743	Processa Pharmaceuticals Inc.	PCSA	Pharmaceutical Preparations (2834)	451539785

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1681718	H James Stanker	C/O Processa Pharmaceuticals, Inc. 7300 Coca Cola Drive, Suite 106 Hanover MD 21076	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-01	6,000	$4.00	47,248	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This amended Form 4 is being filed to correct the purchase price for the reported transaction.